Dr. John Studd
clinical gynaecologist

print this pageHRT

REFERENCES

1. Ross P.K., Pagannini-Hill A., Mack I. et al Menopausal oestrogen therapy and protection from death from ischemic heart disease. Lancet 1981:1:858-60
2. Henderson V.W., Pagannini-Hill A., Emanuel C.K. et al Estrogen replacement therapy in older women: comparisons between Alzheimer�s disease cases and nondemented control subjects. Arch Neurol 1994:51:896-900
3. Isaacs A.J., Britton A.R., McPherson K. Utilisation of hormone replacement therapy by women doctors BMJ 1995:311: 1399-1401
4. Spector T.D. Use of oestrogen replacement therapy in high risk groups in the United Kingdom Br Med J 1989:299:1434-5
5. Studd J.W.W. Continuation rates with cyclical and continuous regimens of oral oestrogens and progestogens. Menopause 1996:3:181-2
6. Holland E.F.N., Leather A.T., Studd J.W.W. and Garnett T.J. (1993). The effect of a new sequential oestradiol valerate and levornorgestrel on the bone mineral density of postmenopausal women. BJOG 100 966-967
7. Studd J.W.W., Holland E.F.N., Leather A. et al The dose-response of percutaneous oestradiol implants on the skeletons of postmenopausal women. Br J Obstet Gynaecol 1994:101:787-91
8. Khastgir G., Studd J. W.W., Holland E.F.N., Alaghband-Zadeh J., Fox S. And Chow J. Histomorphometric changes in bone after long-term percutaneous oestrogen replacement in older postmenopausal women with low bone mineral density. Current Research in Osteoporosis and Bone Mineral Measurement V (1988) Unpublished
9. Brincat M., Moniz C.F., Studd J.W.W. et al Sex hormones and skin collagen content in post-menopausal women. Br Med J 1983:287:1337-8
10. Colditz G.A., Hankinsson S.E., Hunter D.J. et al The use of oestrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995:332:1589-93

^top

void